Abstract:Silk fibroin (SF) is a biomacromolecule that can be assembled into nanostructures and induce biomimetic nucleation of inorganic materials. Zeolitic imidazolate framework-8 (ZIF-8), a metal–organic framework (MOF), can be dissolved selectively under acidic pH. Here, we integrated SF and ZIF-8 to develop novel drug carriers that selectively release drug in the acidic intracellular environment of cancer cells. Specifically, SF was assembled into nanoparticles (SF-NPs), which were then loaded with an antitumor drug, doxorubicin (DOX), to form DSF-NPs. Due to the SF-mediated organization of ZIF-8 precursors such as zinc ions, the DSF-NPs further templated the nucleation of ZIF-8 onto their surface to generate core–shell-structured NPs (termed ) with ZIF-8 as a shell and DSF-NP as a core. We found that the , highly stable under neutral conditions, could be uptaken by breast cancer cells, release DOX selectively owing to dissolution of ZIF-8 shells in the acidic intracellular environment in a controlled manner, and induce cell apoptosis. We also confirmed that the could inhibit tumor growth more efficiently to reach a higher survival rate than their controls by inducing cell apoptosis in vivo. Our study suggests that SF and MOF could be combined to design a new type of cancer therapeutics.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.1c13405.Materials characterization, intracellular location, and biocompatibility; elemental line mapping of ; FTIR spectra of ZIF-8, , and SF-NPs; size distribution of DSF-NPs and ; loading capacity and EE of DOX onto SF-NPs with various concentrations; relative viability of MCF-7 cells cocultured with NPs; fluorescent images of the MCF-7 cells cocultured with FITC-labeled NPs; TEM images of (50 μg/mL) cocultured with MCF-7 cells for 12 h; H&E staining of normal organs (heart, spleen, lung, liver, and kidney) excised from the mice bearing MCF-7 tumors and treated with different NPs and their controls; polydispersity index of DSF-NPs and ; and chemical element analysis of (PDF)This article has not yet been cited by other publications.

Construction of functionalized ruthenium-modified selenium coated with pH-responsive silk fibroin nanomaterials enhanced anticancer efficacy in hepatocellular cancer

Fabrication of novel ruthenium loaded silk fibroin nanomaterials for fingolimod release improved antitumor efficacy in hepatocellular carcinoma

A convergent fabrication of pH and redox dual-responsive hybrids of mesoporous silica nanoparticles for the treatment of breast cancer

Facile fabrication of silk sericin-coated zeolitic imidazolate framework-8 nanocarriers encapsulating cabazitaxel for the treatment of liver cancer cells and their cell death mechanism

Biomimetic Nucleation of Metal–Organic Frameworks on Silk Fibroin Nanoparticles for Designing Core–Shell-Structured pH-Responsive Anticancer Drug Carriers

Construction of a Cancer-Targeted Nanosystem As a Payload of Iron Complexes to Reverse Cancer Multidrug Resistance.

Inhibition of tumor growth and vasculature and fluorescence imaging using functionalized ruthenium-thiol protected selenium nanoparticles.

Rational design of cancer-targeted selenium nanoparticles to antagonize multidrug resistance in cancer cells.

Rational design and fabrication of a cancer-targeted chitosan nanocarrier to enhance selective cellular uptake and anticancer efficacy of selenocystine

Construction of Highly Stable Selenium Nanoparticles Embedded in Hollow Nanofibers of Polysaccharide and Their Antitumor Activities

Improving the anticancer efficacy of laminin receptor-specific therapeutic ruthenium nanoparticles (RuBB-loaded EGCG-RuNPs) via ROS-dependent apoptosis in SMMC-7721 cells.

Biomimetic Nucleation of Manganese Oxide on Silk Fibroin Nanoparticles for Designing Raspberry‐Structured Tumor Environment‐Responsive Anticancer Nanocarriers

Cancer-targeting Functionalization of Selenium-Containing Ruthenium Conjugate with Tumor Microenvironment-Responsive Property to Enhance Theranostic Effects.

Ph-Responsive Cancer-Targeted Selenium Nanoparticles: a Transformable Drug Carrier with Enhanced Theranostic Effects.

Iron-engineered Mesoporous Silica Nanocatalyst with Biodegradable and Catalytic Framework for Tumor-Specific Therapy

Biomineralization-inspired Crystallization of Manganese Oxide on Silk Fibroin Nanoparticles for in vivo MR/fluorescence Imaging-assisted Tri-modal Therapy of Cancer

Silk Fibroin-Coated Nanoagents for Acidic Lysosome Targeting by a Functional Preservation Strategy in Cancer Chemotherapy.

Controlled Synthesis and Size Effects of Multifunctional Mesoporous Silica Nanosystem for Precise Cancer Therapy

Targeted Therapeutic-Immunomodulatory Nanoplatform Based on Noncrystalline Selenium

Fabrication and biofunctionalization of selenium-polypyrrole core-shell nanoparticles for targeting and imaging of cancer cells.

Fabrication of a pH/Redox-Triggered Mesoporous Silica-Based Nanoparticle with Microfluidics for Anticancer Drugs Doxorubicin and Paclitaxel Codelivery